Answer
The Tapimio prolonged-release capsule product information reports an average terminal half-life of 5–6 hours for tapentadol after oral administration.
Sources for this answer
- Tapimio 50 mg prolonged-release capsulesNeuraxpharm UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 1Document updated
Sources checked